Safety Profile Overview
Broad-spectrum anticonvulsant with favorable pharmacokinetic profile. Behavioral adverse effects including irritability and aggression are monitored.
Generic Name
levetiracetam
Brand Names
Keppra
Therapeutic Class
Anticonvulsant
Manufacturer
UCB
What Pharma Signal Tracks for Levetiracetam
- Adverse Events (FAERS) — All FDA Adverse Event Reporting System reports mentioning Levetiracetam, including serious outcomes, hospitalizations, and deaths.
- FDA Recalls — Class I, II, and III recalls, market withdrawals, and safety alerts related to Levetiracetam products.
- Label Changes — Boxed warning additions, new contraindications, dosing modifications, and safety-related labeling supplements.
- Risk Score — Composite risk score (0–100) combining adverse event rates, recall history, and label severity with explainable breakdown.
- Pharmacovigilance Signals — Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) analysis detecting disproportionate adverse reactions.
- Trend Analysis — Monthly time series with anomaly detection for emerging safety signals.
Data Disclaimer: Pharma Signal aggregates data from the FDA Adverse Event Reporting System (FAERS) and other public regulatory sources. FAERS reports do not establish causation. Report counts may reflect prescription volume rather than relative safety. Always consult healthcare professionals for medical decisions.
Get Levetiracetam Safety Data via API
One API call returns adverse events, risk scores, recalls, and pharmacovigilance signals for Levetiracetam.
curl "https://api.pharma-signal.com/drug/safety/levetiracetam" \ -H "X-API-Key: your_key" # Returns risk score, adverse event counts, # serious/death rates, recalls, and signals
Related Safety Intelligence
Pharma Signal provides comparative analysis across therapeutic classes. Compare Levetiracetam against other Anticonvulsant drugs, or explore the full manufacturer portfolio for UCB.
- Head-to-head comparison — Compare up to 5 drugs side by side on all safety metrics.
- Therapeutic class benchmarking — See how Levetiracetam ranks within Anticonvulsant on serious event rates.
- Company portfolio risk — View all drugs from UCB with aggregate risk exposure.
- AI analyst briefs — Get a natural-language safety assessment combining all data sources.